300 related articles for article (PubMed ID: 28184417)
1. New agents on the horizon in gastric cancer.
Lordick F; Shitara K; Janjigian YY
Ann Oncol; 2017 Aug; 28(8):1767-1775. PubMed ID: 28184417
[TBL] [Abstract][Full Text] [Related]
2. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023.
Wang FH; Zhang XT; Tang L; Wu Q; Cai MY; Li YF; Qu XJ; Qiu H; Zhang YJ; Ying JE; Zhang J; Sun LY; Lin RB; Wang C; Liu H; Qiu MZ; Guan WL; Rao SX; Ji JF; Xin Y; Sheng WQ; Xu HM; Zhou ZW; Zhou AP; Jin J; Yuan XL; Bi F; Liu TS; Liang H; Zhang YQ; Li GX; Liang J; Liu BR; Shen L; Li J; Xu RH
Cancer Commun (Lond); 2024 Jan; 44(1):127-172. PubMed ID: 38160327
[TBL] [Abstract][Full Text] [Related]
3. [Surgical management of gastric cancer in the era of immunotherapy].
Li ZY; Jia YN; Lu XX; Guan GM; Wang Q
Zhonghua Wai Ke Za Zhi; 2024 May; 62(5):353-358. PubMed ID: 38548601
[TBL] [Abstract][Full Text] [Related]
4. The preclinical discovery and development of zolbetuximab for the treatment of gastric cancer.
Zeng Y; Lockhart AC; Jin RU
Expert Opin Drug Discov; 2024 Jun; ():1-14. PubMed ID: 38919123
[TBL] [Abstract][Full Text] [Related]
5. Cancer Biology, Epidemiology, and Treatment in the 21st Century: Current Status and Future Challenges From a Biomedical Perspective.
Piña-Sánchez P; Chávez-González A; Ruiz-Tachiquín M; Vadillo E; Monroy-García A; Montesinos JJ; Grajales R; Gutiérrez de la Barrera M; Mayani H
Cancer Control; 2021; 28():10732748211038735. PubMed ID: 34565215
[TBL] [Abstract][Full Text] [Related]
6. Predictive Factors of Immunotherapy in Gastric Cancer: A 2024 Update.
Bintintan V; Burz C; Pintea I; Muntean A; Deleanu D; Lupan I; Samasca G
Diagnostics (Basel); 2024 Jun; 14(12):. PubMed ID: 38928662
[TBL] [Abstract][Full Text] [Related]
7. Gastric cancer.
Smyth EC; Nilsson M; Grabsch HI; van Grieken NC; Lordick F
Lancet; 2020 Aug; 396(10251):635-648. PubMed ID: 32861308
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for Esophageal and Gastric Cancer.
Kelly RJ
Am Soc Clin Oncol Educ Book; 2017; 37():292-300. PubMed ID: 28561677
[TBL] [Abstract][Full Text] [Related]
9. Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer.
Singh P; Toom S; Huang Y
J Hematol Oncol; 2017 May; 10(1):105. PubMed ID: 28494772
[TBL] [Abstract][Full Text] [Related]
10. Role of modern immunotherapy in gastrointestinal malignancies: a review of current clinical progress.
Myint ZW; Goel G
J Hematol Oncol; 2017 Apr; 10(1):86. PubMed ID: 28434400
[TBL] [Abstract][Full Text] [Related]
11. The Evolving Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancer.
Murphy AG; Kelly RJ
Hematol Oncol Clin North Am; 2017 Jun; 31(3):485-498. PubMed ID: 28501089
[TBL] [Abstract][Full Text] [Related]
12. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Kang YK; Boku N; Satoh T; Ryu MH; Chao Y; Kato K; Chung HC; Chen JS; Muro K; Kang WK; Yeh KH; Yoshikawa T; Oh SC; Bai LY; Tamura T; Lee KW; Hamamoto Y; Kim JG; Chin K; Oh DY; Minashi K; Cho JY; Tsuda M; Chen LT
Lancet; 2017 Dec; 390(10111):2461-2471. PubMed ID: 28993052
[TBL] [Abstract][Full Text] [Related]
13. Overcoming resistance to HER2-targeted therapy with a novel HER2/CD3 bispecific antibody.
Lopez-Albaitero A; Xu H; Guo H; Wang L; Wu Z; Tran H; Chandarlapaty S; Scaltriti M; Janjigian Y; de Stanchina E; Cheung NK
Oncoimmunology; 2017; 6(3):e1267891. PubMed ID: 28405494
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer.
Su S; Zou Z; Chen F; Ding N; Du J; Shao J; Li L; Fu Y; Hu B; Yang Y; Sha H; Meng F; Wei J; Huang X; Liu B
Oncoimmunology; 2017; 6(1):e1249558. PubMed ID: 28197365
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers.
Liu Y; Cheng Y; Xu Y; Wang Z; Du X; Li C; Peng J; Gao L; Liang X; Ma C
Oncogene; 2017 Nov; 36(44):6143-6153. PubMed ID: 28692048
[TBL] [Abstract][Full Text] [Related]
16. The novel negative checkpoint regulator VISTA is expressed in gastric carcinoma and associated with PD-L1/PD-1: A future perspective for a combined gastric cancer therapy?
Böger C; Behrens HM; Krüger S; Röcken C
Oncoimmunology; 2017; 6(4):e1293215. PubMed ID: 28507801
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for gastric cancers: emerging role and future perspectives.
Bonotto M; Garattini SK; Basile D; Ongaro E; Fanotto V; Cattaneo M; Cortiula F; Iacono D; Cardellino GG; Pella N; Fasola G; Antonuzzo L; Silvestris N; Aprile G
Expert Rev Clin Pharmacol; 2017 Jun; 10(6):609-619. PubMed ID: 28349740
[TBL] [Abstract][Full Text] [Related]
18. Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial.
Shitara K; Özgüroğlu M; Bang YJ; Di Bartolomeo M; Mandalà M; Ryu MH; Fornaro L; Olesiński T; Caglevic C; Chung HC; Muro K; Goekkurt E; Mansoor W; McDermott RS; Shacham-Shmueli E; Chen X; Mayo C; Kang SP; Ohtsu A; Fuchs CS;
Lancet; 2018 Jul; 392(10142):123-133. PubMed ID: 29880231
[TBL] [Abstract][Full Text] [Related]
19. Biogenesis, functions and clinical significance of circRNAs in gastric cancer.
Shan C; Zhang Y; Hao X; Gao J; Chen X; Wang K
Mol Cancer; 2019 Sep; 18(1):136. PubMed ID: 31519189
[TBL] [Abstract][Full Text] [Related]
20. A Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab with or without Alpelisib in Metastatic
van Geel RMJM; Tabernero J; Elez E; Bendell JC; Spreafico A; Schuler M; Yoshino T; Delord JP; Yamada Y; Lolkema MP; Faris JE; Eskens FALM; Sharma S; Yaeger R; Lenz HJ; Wainberg ZA; Avsar E; Chatterjee A; Jaeger S; Tan E; Maharry K; Demuth T; Schellens JHM
Cancer Discov; 2017 Jun; 7(6):610-619. PubMed ID: 28363909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
